Literature DB >> 8034746

v-src transformation of rat embryo fibroblasts. Inefficient conversion to anchorage-independent growth involves heterogeneity of primary cultures.

N Tavoloni1, H Inoue, H Sabe, H Hanafusa.   

Abstract

To clarify whether a single oncogene can transform primary cells in culture, we compared the transforming effect of a recombinant retrovirus (ZSV) containing the v-src gene in rat embryo fibroblasts (REFs) to that in the rat cell line 3Y1. In the focus assay, REFs exhibited resistance to transformation as only six foci were observed in the primary cultures as opposed to 98 in 3Y1 cells. After G418 selection, efficiency of transformation was again somewhat lower with REFs compared to that with 3Y1 cells, but the number of G418-resistant REF colonies was much greater than the number of foci in REF cultures. Furthermore, while 98% of G418-resistant colonies of ZSV-infected REFs were morphologically transformed, only 25% were converted to anchorage-independent growth, as opposed to 100% conversion seen in ZSV-infected 3Y1 cells. The poor susceptibility of REFs to anchorage-independent transformation did not involve differences in expression and subcellular distribution of p60v-src, or its kinase activity in vitro and in vivo. It rather reflected a property of the primary cultures, as cloning of REFs before ZSV infection demonstrated that only 2 out of 6 REF clones tested were permissive for anchorage-independent growth. The nonpermissive phenotype was dominant over the permissive one in somatic hybrid cells, and associated with organized actin filament bundles and a lower growth rate, both before and after ZSV infection. These results indicate that the poor susceptibility of REFs to anchorage-independent transformation by p60v-src reflects the heterogeneity of the primary cultures. REFs can be morphologically transformed by p60v-src with high efficiency but only a small fraction is convertible to anchorage-independent growth. REF resistance seems to involve the presence of a suppressor factor which may emerge from REF differentiation during embryonic development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034746      PMCID: PMC2200037          DOI: 10.1083/jcb.126.2.475

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  47 in total

1.  Cytoskeletal organization, vinculin-phosphorylation, and fibronectin expression in transformed fibroblasts with different cell morphologies.

Authors:  E A Nigg; B M Sefton; S J Singer; P K Vogt
Journal:  Virology       Date:  1986-05       Impact factor: 3.616

2.  Cooperative transforming activities of ras, myc, and src viral oncogenes in nonestablished rat adrenocortical cells.

Authors:  A MacAuley; T Pawson
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

3.  myc and src oncogenes have complementary effects on cell proliferation and expression of specific extracellular matrix components in definitive chondroblasts.

Authors:  S Alema; F Tato; D Boettiger
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

Review 4.  Cell transformation by the viral src oncogene.

Authors:  R Jove; H Hanafusa
Journal:  Annu Rev Cell Biol       Date:  1987

5.  Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts.

Authors:  H Land; A C Chen; J P Morgenstern; L F Parada; R A Weinberg
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

6.  Oncogene v-src transforms and establishes embryonic rodent fibroblasts but not diploid human fibroblasts.

Authors:  B Hjelle; E Liu; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

7.  Association of p60src with Triton X-100-resistant cellular structure correlates with morphological transformation.

Authors:  M Hamaguchi; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

Review 8.  Precursor lesions for liver cancer in humans.

Authors:  P P Anthony
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

9.  Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine.

Authors:  M P Kamps; B M Sefton
Journal:  Oncogene       Date:  1988-04       Impact factor: 9.867

10.  Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation.

Authors:  M P Kamps; J E Buss; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

View more
  6 in total

1.  Suppression of v-src transformation by the drs gene.

Authors:  H Inoue; J Pan; A Hakura
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

2.  Cellular aging is a critical determinant of primary cell resistance to v-src transformation.

Authors:  N Tavoloni; H Inoue
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

3.  Expression of the pRb-binding regions of E1A enables efficient transformation of primary epithelial cells by v-src.

Authors:  R S Fischer; M P Quinlan
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

Review 4.  Mechanisms of oncogenic cooperation in cancer initiation and metastasis.

Authors:  Laura G Pedraza-Fariña
Journal:  Yale J Biol Med       Date:  2006-12

5.  A p130Cas tyrosine phosphorylated substrate domain decoy disrupts v-crk signaling.

Authors:  Kathrin Kirsch; Margaret Kensinger; Hidesaburo Hanafusa; Avery August
Journal:  BMC Cell Biol       Date:  2002-07-15       Impact factor: 4.241

6.  Neoplastic transformation of rat colon epithelial cells by expression of activated human K-ras.

Authors:  K Sugiyama; K Otori; H Esumi
Journal:  Jpn J Cancer Res       Date:  1998-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.